Business Context and Reporting Period
Company: Ultralife Batteries, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: Ultralife is a global provider of power solutions, developing and manufacturing non-rechargeable and rechargeable lithium batteries for military, industrial, and consumer applications. The company operates in three segments: Non-Rechargeable Batteries, Rechargeable Batteries, and Technology Contracts.
Key Financial Metrics (Year Ended Dec 31, 2004)
| Metric | Value (in thousands) |
|---|---|
| Total Revenues | $98,182 |
| Gross Margin | $20,302 (21% of revenue) |
| Operating Income | $5,095 |
| Net Income | $22,332 |
| Earnings Per Share (Diluted) | $1.48 |
| Cash and Cash Equivalents | $10,529 |
| Total Assets | $81,134 |
| Total Long-Term Debt | $7,215 |
| Working Capital | $30,645 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 24% to $98.2 million from $79.5 million in 2003. This was driven by a 14% increase in Non-Rechargeable sales (military demand) and a 428% surge in Rechargeable sales.
- Net Income Surge: Net income jumped to $22.3 million from $6.4 million in 2003. This significant increase was primarily due to a $21.1 million non-cash deferred income tax credit resulting from the recognition of a deferred tax asset related to Net Operating Loss (NOL) carryforwards.
- Impairment Charges: The company recorded a $1.8 million impairment charge in December 2004 related to polymer rechargeable manufacturing assets, following a strategic decision to cease manufacturing polymer rechargeable cells.
- Investment Write-off: A $3.95 million non-cash charge was recorded for the write-off of a note receivable and equity investment in Ultralife Taiwan, Inc. (UTI) due to UTI's financial instability.
- Segment Performance:
- Non-Rechargeable: Revenue $87.9 million; Contribution $20.5 million.
- Rechargeable: Revenue $8.1 million; Contribution loss of $0.6 million.
- Technology Contracts: Revenue $2.2 million; Contribution $0.4 million.
- Corporate: Contribution loss of $15.2 million.
Guidance, Outlook, and Risks
Management Outlook
- 2005 Revenue: Projected to increase 10% to 20% over 2004 levels.
- 2005 Operating Income: Expected to return to profitability in Q2, targeting a 15% operating margin by year-end.
- Q1 2005 Projection: Revenues of approximately $18 million and an operating loss of approximately $0.8 million.
- Long-term Targets: Targeting 30% gross margins and 20% operating margins as revenues approach $50 million per quarter.
Key Risks and Contingencies
- Government Contract Protests: Competitors have protested two major U.S. military contract awards (Next Gen II Phase IV and BA-5347/U) totaling up to $301 million. These protests prevent the government from proceeding with the contracts until resolved, creating revenue timing uncertainty.
- Customer Concentration: The U.S. Army/CECOM (now DLA) accounted for approximately 55% of 2004 revenues. Loss of this customer would have a material adverse effect.
- Environmental Liability: Ongoing remediation of contaminated soil and groundwater at the Newark, NY facility. Estimated costs were $230,000, with $100,000 incurred through 2004; final costs remain uncertain.
- Fire Incidents: Two fires occurred in 2004 (May in U.S., June in U.K.) causing inventory and property damage. The company expects to be fully reimbursed by insurance.
- Debt Covenants: The company must maintain specific financial ratios (Debt to Earnings, EBIT to Interest). Adverse changes could limit borrowing capacity.
Investor Verification Checklist
- Contract Protest Resolution: Monitor the status of the protests against the $286 million Next Gen II Phase IV and $15 million BA-5347/U contracts.
- Tax Asset Realization: Verify the company's ability to utilize NOL carryforwards to offset future taxable income, noting the Section 382 annual limitation of approximately $22 million.
- UTI Financial Health: Assess the financial stability of Ultralife Taiwan, Inc. (UTI), a key supplier, given the recent write-off of the company's investment and note receivable.
- Environmental Costs: Track updates on the Newark facility remediation to ensure costs do not exceed current estimates.
- Stock-Based Compensation: Note the upcoming adoption of SFAS 123R in 2005, which will require expensing stock options and is expected to negatively impact net income.